Study of Cyclosporine in Post-LASIK Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

621

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Laser In Situ Keratomileusis
Interventions
DRUG

Cyclosporine 0.010% eye drops

Cyclosporine 0.010% eye drops administered as 1 drop to each eye twice daily (morning and evening) for at least 2 weeks prior to LASIK surgery and up to 7 months post-LASIK surgery.

DRUG

Cyclosporine 0.005% eye drops

Cyclosporine 0.005% eye drops administered as 1 drop to each eye twice daily (morning and evening) for at least 2 weeks prior to LASIK surgery and up to 7 months post-LASIK surgery.

DRUG

Placebo (Vehicle for Cyclosporine)

Placebo eye drops administered as 1 drop to each eye twice daily (morning and evening) for at least 2 weeks prior to LASIK surgery and up to 7 months post-LASIK surgery.

Trial Locations (1)

Unknown

Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY